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The contractile perivascular cells, pericytes (PC), are hijacked by
glioblastoma (GB) to facilitate tumor progression. PC’s protumori-
genic function requires direct interaction with tumor cells and con-
tributes to the establishment of immunotolerance to tumor growth.
Cancer cells up-regulate their own chaperone-mediated autophagy
(CMA), a process that delivers selective cytosolic proteins to lyso-
somes for degradation, with pro-oncogenic effects. However, the
possible impact that cancer cells may have on CMA of surrounding
host cells has not been explored. We analyzed the contribution of
CMA to the GB-induced changes in PC biology. We have found that
CMA is markedly up-regulated in PC in response to the oxidative
burst that follows PC–GB cell interaction. Genetic manipulations to
block the GB-induced up-regulation of CMA in PC allows them to
maintain their proinflammatory function and to support the induc-
tion of effective antitumor T cell responses required for GB clear-
ance. GB-induced up-regulation of CMA activity in PC is essential for
their effective interaction with GB cells that help tumor growth. We
show that CMA inhibition in PC promotes GB cell death and the
release of high immunogenic levels of granulocyte-macrophage col-
ony stimulating factor (GM-CSF), through deregulation of the ex-
pression of cell-to-cell interaction proteins and protein secretion. A
GB mouse model grafted in vivo with CMA-defective PC shows re-
duced GB proliferation and effective immune response compared to
mice grafted with control PC. Our findings identify abnormal up-
regulation of CMA as a mechanism by which GB cells elicit the im-
munosuppressive function of PC and stabilize GB–PC interactions
necessary for tumor cell survival.
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Glioblastoma multiforme (GB) is the most common and ag-gressive brain tumor. GB usually has a poor prognosis, with
a median survival of 14 to 16 mo (1, 2). During its development,
tumor cells infiltrate and invade the brain parenchyma, interacting
with cells from perivascular areas and establishing a functional
network of ultralong, microtube-like actin-rich membrane pro-
trusions from GB (3–5). In recent years, several mechanisms have
been reported to facilitate GB progression (6–10), including those
requiring GB cell interactions with host cells for intercommuni-
cation and delivery of organelles and nutrients required to ensure
tumor survival (3, 4, 11).
GB infiltrates the perivascular space and brain microvessels,
which are composed of pericytes (PC) and endothelial cells (4, 11–
13). PC are perivascular stromal cells that are situated on the
abluminal vessel wall of brain capillaries. PC control multiple
neurovascular functions and are required for neuronal homeo-
stasis (14–16). PC regulate vessel tone and morphology, angio-
genesis, and capillary hemodynamics (13–15). PC also contribute
to the maintenance of the blood–brain barrier integrity through
the elimination of toxic products, the control of the expression of
endothelial tight junction and adherens proteins, and the regula-
tion of vesicle trafficking (13–15, 17, 18).
PC may also develop stem cell-like properties, and release
proregenerative growth factors and extracellular vesicles (18–20).
PC are able to phagocytose and have the ability to promote
inflammation in response to brain damage (16, 19), enhancing
blood–brain barrier disruption through paracrine secretion of
several vasculotoxic molecules and reactive oxygen species (ROS)
(16, 18, 19). However, PC fail to contribute to the elimination of
GB. The changes in PC biology that occur in response to the
presence of GB tumor cells is not well understood yet.
We have recently shown that PC have an immunosuppressive
function during GB progression, which contributes to the estab-
lishment of immune tolerance to the tumor and, therefore, to
tumor growth (4). This switch in PC immune function is dependent
on direct interactions between PC and tumor cells, which condi-
tion PC to develop an antiinflammatory phenotype responsi-
ble for the failure to activate T cell responses and the absence
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of immune-mediated tumor clearance. Upon GB interaction, PC
express high levels of the antiinflammatory cytokines IL-10 and
TGF-β, and show decreased expression of the costimulatory
molecules CD80 and CD86 and of histocompatibility complex
molecules, MHC-II (4, 6, 7). Importantly, under those conditions,
PC express the immunosuppressive PDL-1 ligand that can bind to
programmed cell death 1 (PD-1) receptor expressed by T cells in
the infiltrated GB perivascular areas (4, 7).
The molecular mechanisms underlying interactions between
cancer cells and PC remain poorly characterized. Deciphering
these mechanisms should lead to a better understanding of the host
brain microenvironment during GB development and, most im-
portantly, may allow finding novel therapeutic targets for effective
GB treatment.
The GB-induced phenotypic switch of PC from pro- to antiin-
flammatory phenotype likely requires major changes of the PC
proteome. Protein remodeling can be attained through changes
in transcriptional programs as well as through active removal
of proteins whose function needs to be terminated. Selective
degradation of intracellular proteins occurs mainly via the ubiq-
uitin proteasome system or by selective forms of autophagy.
Chaperone-mediated autophagy (CMA) is a selective form of
autophagy responsible for the targeted and timely degradation of
soluble cytosolic proteins that have specific targeting motifs (bio-
chemical related to the pentapeptide KEFRQ) in their amino acid
sequence (21, 22). The cytosolic chaperone Hsc70 recognizes this
motif and transports substrate proteins to the lysosomes (23).
There, they are unfolded and transported into the lysosomal lu-
men for degradation through a translocation complex formed by
multimers of the lysosomal receptor for CMA, LAMP-2A (24, 25).
CMA activity is directly dependent on the levels of LAMP-2A at
the lysosomal membrane, since the binding of substrate proteins to
LAMP-2A is a limiting step for this pathway (22, 25). Lysosomal
levels of LAMP-2A are usually regulated through changes in the
turnover and intralysosomal distribution of this protein, and do
not usually involve de novo protein synthesis (22). However, under
conditions requiring maximal activation of this autophagic path-
way, such as in response to oxidative stress, activation of CMAmay
occur through up-regulation of the expression of Lamp2a and
synthesis of new proteins (26, 27). Regulation of the activity of CMA
is critical to maintain cell function and homeostasis, as its failure
leads to the intracellular accumulation of damaged proteins, de-
fective regulation of many cellular processes, and altered responses
to different stresses, such as nutrient deprivation, oxidative stress, or
toxic exposure (25, 27, 28). CMA has been described as a regulatory
mechanism of the function of some immune cells (26, 29); however,
its role in PC is unknown. In this work, we have analyzed the con-
tribution of CMA to the GB-induced PC phenotypic switch.
The immune function of PC may require tight regulation of
levels of positive and negative regulators of signaling pathways that
are induced by the interaction of these cells with GB (30–32). The
ability of CMA to selectively degrade proteins in response to
specific stimuli makes this mechanism an attractive candidate
to contribute to the GB-induced functional switch in PC. We
propose that CMA plays a role in the regulation of the ability of
PC to modulate inflammation and, therefore, in the subsequent
immune response in the perivascular niche to the presence of GB.
Here, we present evidence that GB induces abnormal basal
CMA up-regulation in PC, which is required to induce an im-
munosuppressive phenotype in PC that facilitates tumor progres-
sion. CMA also contributes to maintaining the stability of PC–GB
interactions that GB needs to survive. Inhibition of CMA in PC
promotes a secretory phenotype that contributes to the elimination
of the tumor cells, and enhances changes in the immune properties
of PC that prevent tumor progression.
Results
LAMP-2A Expression and CMA Activity Are Up-Regulated in PC in
Response to the Oxidative Burst That Follows PC–GB Cell Interaction.
PC acquire an immunosuppressive phenotype in response to direct
GB interaction (GB-conditioned PC; GBCPC) (4). CMA can be
utilized by different cell types to regulate their proteome through
selective degradation of proteins and modulate their response to a
wide variety of stimuli (22, 32). To determine if CMA contributed
to the modulation of the functional switch that PC undergo during
GB progression, we analyzed if LAMP-2A protein levels changed
in PC following interaction with GB. Immunoblots of mouse
LAMP-2A showed a marked increase of the levels of this protein
in PC when grown in the presence of human GB (GBCPC) (Fig.
1A). In addition, increased LAMP-2A protein levels correlated
with an up-regulation of Lamp2a mRNA expression (Fig. 1B).
Corroborating these data, an increase of luciferase activity, with
similar kinetics to the induction of endogenous Lamp2a mRNA in
GBCPC, was detected in PC transfected with a luciferase reporter
vector controlled by the proximal promoter of the Lamp2 gene
(26) (SI Appendix, Fig. S1A).
In order to analyze if increased LAMP-2A protein levels in GBCPC
required direct cell-to-cell interactions or was mediated by soluble
molecules released by GB cells, we incubated PC for 48 h with se-
quential dilutions of supernatants obtained from GB cultures. Under
these conditions, we did not find significant differences in Lamp2a
expression when compared to the levels of Lamp2a mRNA in PC
grown in control media (Fig. 1C). Immunofluorescence analyses
using anti–LAMP-2A antibodies also evidenced increased
LAMP-2A+ puncta in GBCPC (Fig. 1D). However, flow cytometry
analysis using the fluorescent lysosomal probe lysotracker did not
show any difference in the total amounts of lysosomes in PC, whether
conditioned or not by GB (Fig. 1E and SI Appendix, Fig. S1B),
supporting the finding that the observed increase in LAMP-2A was
not just a result of expansion of the lysosomal compartment but
rather an increased level of LAMP-2A protein in lysosomes.
To determine if the increase in LAMP-2A protein levels resulted
in higher CMA activity, we transfected PC with a vector that directs
the expression of KFERQ-PA-mCherry-1, a photoactivable CMA
reporter that allows monitoring CMA activity in living cells (33).
Photoactivation of the KFERQ-PA-mCherry-1 reporter allows for
detection of CMA activity by evaluating the numbers of mCherry+
puncta, which result from the redistribution of the artificial fluo-
rescent CMA substrate from the cytosol to the membrane of CMA-
active lysosomes. Coculture of PC with GB cells significantly
increased the number of mCherry+ puncta per cell, supporting
the finding that GB interaction induces CMA in PC (Fig. 1F).
An inhibitor of macroautophagy, 3-methyladenine (3-MA), which
has no effect on CMA, was used as control to confirm that
mCherry cellular redistribution was not a consequence of activa-
tion of macroautophagy (Fig. 1F).
ROS release is known to regulate PC contractile properties in
response to stressors to maintain blood vessel tone (18, 34); how-
ever, oxygen conditions in the perivascular invasive niche of GB
have not been well defined (1). As mild oxidative stress activates
CMA in several cell types through transcriptional up-regulation of
Lamp2a, we analyzed if ROS production could be responsible for
the increased Lamp2a expression in PC upon GB interaction. Sur-
prisingly, whereas compared to basal levels no significant differences
in ROS production were found in PC conditioned by culture with
GB cells for 12 h (GBCPC), GB cells produced higher levels of ROS
in response to PC interaction (PCCGB) compared to basal levels
(Fig. 1G). To determine if this increase in ROS production by GB
could contribute to the up-regulation of Lamp2a expression in PC,
we treated cocultures of PC and GB with N-acetylcysteine (NAc), a
ROS scavenger. In the presence of NAc, coculture with GB failed to
induce an increase of the LAMP-2A protein levels in PC (Fig. 1H).
In summary, our data support that the oxidative burst occurring in
GB, caused by interaction with PC, could be responsible for the
observed GB-mediated induction of CMA in PC.
GB-Induced CMA Activity in PC Is Required for the Acquisition of an
Immunosuppressive Function in PC Following Interaction with GB. To
determine if CMA activity was necessary for the establishment of
the immunosuppressive function that PC acquire in response to
interaction with GB (4), we isolated brain PC from WT control
(WT PC) and LAMP-2A knockout (KO PC) mice (26) (Fig. 2A).





















































Then, we analyzed the ability of WT and KO PC, previously
conditioned or not by GB cells, to present ovalbumin (OVA)323–329
peptide and activate OVA-peptide specific T cell receptor (TCR)
transgenic OT-II CD4+ T cells. As we had previously reported, the
ability of WT PC to activate T cell responses was suppressed by the
interaction with GB (4). However, in PC with impaired CMA ac-
tivity (KO PC), interaction with GB failed to suppress the ability of
PC to activate OT-II cells, and T cells maintained high levels of
IL-2 production (Fig. 2B) and cell proliferation (Fig. 2C), even in
the presence of GB cells. A reduced sensitivity of GB-mediated
inhibition of PC’s ability to activate T cells was also observed
when Lamp2a expression was silenced in PC using short-hairpin
RNA (shRNA) (SI Appendix, Fig. S1 C and D). Expression of the
costimulatory molecule CD80 was markedly reduced in GBCWT PC
compared toWT PC, but remained unaltered in GBCKO PC (Fig. 2D).
Furthermore, the antiinflammatory phenotype that develops in
GBCWT PC was also altered in CMA-deficient GBCKO PC,
which showed reduced mRNA level expression of Tgfb and Il10
(Fig. 2E) and higher levels of the proinflammatory cytokine
TNF-α compared to GBCWT PC (Fig. 2F). In conclusion, these
data suggest that functional CMA activity in PC is essential for the
acquisition of the immunosuppressive function in response to GB
interaction.
GB-Induced CMA in PC Is Required to Stabilize PC–GB Interactions
That Maintain Tumor Cell Survival. GB may rely on their interac-
tions with PC to support optimal proliferation and survival. We
determined if persistence of these interactions required the ob-
served CMA up-regulation in PC, and if, consequently, failure to
activate this autophagic pathway could hinder GB tumor cell
growth and survival. When we measured changes in cell pro-
liferation of GB cells conditioned by WT or KO PC (Fig. 3A), we
observed that GB proliferation was significantly reduced when
grown in the presence of CMA-incompetent PC (KO PCCGB)
compared to control GB cells (GB) or GB cells cultured in presence
of WT PC (WT PCCGB) (Fig. 3A). Interestingly, we found that in GB–
PC cocultures, GB cells showed abundant cell-to-cell interactions with
WT PC, but they did not appear to interact properly with CMA-
deficient KO PC (Fig. 3B and SI Appendix, Fig. S2A). Furthermore,
a higher percentage of cell death was observed in KO PCCGB cells
compared to control GB cells or WT PCCGB (Fig. 3C). Survival of
PC was, however, not significantly affected by the presence of GB or
the absence of CMA (Fig. 3D). Interestingly, similar to what happened
in the presence of KO PC, we found high levels of cell death in GB
cells cocultured with NAc-treated WT PC (SI Appendix, Fig. S2B).
We then proceeded to characterize in more detail the interac-
tions between GB and PC using surface scanning electron mi-
croscopy. We noticed that, as previously described (3), GB cells
interacted with PC through microtube-like ultralong protrusions
(SI Appendix, Fig. S2A), and that PC projected small nanotubes
toward the surface of the GB to sustain interaction (Fig. 3E).
However, we hardly found those structures in KO PC. Instead, we
observed disorganized protrusions in contact areas of KO PC with
GB (Fig. 3 E and F and SI Appendix, Fig. S2A). To confirm these
altered interactions, we also evaluated adhesion of GB to PC by
measuring RFP fluorescence retained on a PC monolayer after
washing away RFP+GB cells that had been cocultured with the PC
monolayer for 24 h. We detected a significant loss of adherence
(∼35%) in GB cocultured with KO PC (Fig. 3G).
Furthermore, scanning microscopy analyses of GB cultured in
the presence of WT or KO PC also revealed a different pattern of
distribution of secretory vesicles in PC. While secretory vesicles
often accumulated in the sites of contact between WT PC and GB,
they were rarely observed in KO PC (SI Appendix, Fig. S2C).
Morphometrics analyses of extracellular vesicles positive for CD63,
a common marker of intracellular vesicle membranes, revealed that
WT PC increased vesicle secretion in response to GB (SI Appendix,
Fig. S3 A and B). Interestingly, although extracellular vesicle number
in KO PC was higher than in WT PC, vesicle abundance remained
unaltered when cultured in the presence of GB. Interestingly, only
vesicles from GBCKO PC cultures were capable of inhibiting GB
Fig. 1. GB interaction activates CMA in PC. (A) Immunoblot of LAMP-2A
(representative of 5 experiments) in whole-cell lysates of GFP-expressing PC
cocultured with GB (GBCPC). LAMP-2A protein levels in human GB cells was used
as negative control for murine LAMP-2A protein levels. Quantification by
densitometry is represented as fold-induction of LAMP-2A levels (GBCPC over PC)
and normalized to GFP. *P < 0.05. (B) Quantification of Lamp2a mRNA ex-
pression by qPCR (relative to PC basal levels) in PC cocultured with GB cells
(GBCPC) (C) Semiquantitative analysis of Lamp2a mRNA expression by qPCR in
PC, after being cultured for 72 h under several conditions (PC alone: PC; PC
grown in presence of GB cells: GBCPC; PC grown in presence of several dilutions
of GB conditioned media: PC + 1/2, 1/4 GB media); **P < 0.01. (D) LAMP-2A
(green) identified by immunofluorescence in PC, under basal conditions and
upon coculture with GB (GBCPC) for 48 h. Nuclei were stained with DAPI (blue).
GB cells were identified by human LAMP-2 protein (yellow). Phalloidin (red) was
used to stain actin cytoskeleton. (Scale bar, 50 μm.). (E) Flow cytometry analysis
of lysosome levels using lysotracker in control PC or GBCPC after 48 h. Gating
strategy to identify DiD+ GB-labeled cell population is shown (Left). Represen-
tative flow cytometry histogram and bar graph showing mean fluorescence
intensity (MFI, normalized to values obtained from PC cultured alone). All data
represent mean ± SD obtained from at least 4 independent experiments using
U373 and U87 GB lines independently. (F) KFERQ-PA-mCherry distribution in PC
transiently transfected with a CMA reporter vector, photoactivated and cocul-
tured with GB cells in the presence or absence of 3-MA. Images show repre-
sentative cells displaying mCherry+ puncta (original magnification, 630×).
Quantification is shown in bar graph (mean + SD of 3 different experiments
with >50 cells counted per experiment) (n = 3; ANOVA with Tukey posttest;
*P < 0.05; **P < 0.01). (G) ROS production measured by flow cytometry using
CM-H2DCFDA in PC conditioned or not by GB cells (GBCPC) and in GB cells
conditioned or not by PC (PCCGB) for 12 h. ROS production was not detected in
initial hours of coculture. Data (mean + SD from 3 different experiments) are
presented as MFI (normalized to values obtained from GB cultured alone);
**P < 0.01. (H) Immunoblot of LAMP-2A in resting PC and PC conditioned by GB
cells (GBCPC) during 48 h in the presence or absence of NAc (representative of 3
different experiments). Quantification of the LAMP2-A levels is represented as
fold-induction and normalized to levels of β-actin of both GB and PC. *P < 0.05.









































































proliferation (SI Appendix, Fig. S3C), suggesting that changes in
CMA result in qualitative differences in vesicle composition/
content rather than just mere changes in their abundance.
Coculture of GB with CMA-Deficient PC Results in the Secretion of
Proteins That Reduce Tumor Cell Survival and Prevent PC–GB
Interactions. To characterize the basis for the increased GB cell
death in the absence of stable PC interactions, we analyzed differ-
ences in danger signals that could be released by GB (1, 8, 35) when
cultured in presence of WT or CMA-deficient KO PC. Levels of
granulocyte-macrophage colony stimulating factor (GM-CSF)
produced by GB almost doubled when cocultured with WT PC,
but secretion of this cytokine was much higher in the presence of
KO PC (Fig. 4A). This increase in GM-CSF secretion by GB
could be recapitulated by using conditioned media obtained
from cocultures of KO PC and GB, but not of WT PC and
GB (Fig. 4B). Furthermore, very high levels of ROS were de-
tected in KO PCCGB at 24 to 72 h of coculture (Fig. 4C), when
GB cell death was occurring (Fig. 3C). Once again, changes in
GB ROS production could be reproduced, even in presence
of WT PC (WT PCCGB), by using culture media from cocultures
of KO PC and GB (Fig. 4D), suggesting that CMA-incompetent
PC exposed to GB may secrete toxic molecules that negatively
impact tumor survival.
We then proceeded to determine if that toxic secreted mole-
cule would also affect the interactions between PC and GB. In-
deed, we found that media obtained from GB-KO PC cocultures
was also sufficient to reduce GB adhesion to WT PC (Fig. 4E),
mimicking what we had seen in cocultures of GB and KO PC. This
effect occurred if cells were treated with conditioned media either
before or after GB–PC cell interactions had been formed, sup-
porting that secreted molecules not only inhibited formation of GB–
PC interactions but also disrupted pre-established ones. Further-
more, we observed that the media from KO PCCGB was also sufficient
to induce GB cell death, not only when cultured alone but also
when GB was grown in the presence of WT PC (Fig. 5 A and B).
To investigate the nature of the molecules that might be secreted
by GBCKO PC, we subjected the conditioned media to treatment
with proteases or ribonucleases. Treatment of conditioned media
from GBCKO PC cultures with trypsin failed to induce GB cell
death, whereas treatment with RNase did not alter the ability of
the conditioned media to induce GB cell death. These findings sup-
port that secreted proteins or peptides are responsible for the toxic
effect of the conditioned media on GB (Fig. 5C). We propose that
these cytotoxic products may be part of the normal proinflammatory
response of PC to the presence of GB, and that GB prevents their
production/secretion by up-regulating CMA in PC cells.
GB-Induced CMA in PC Alters the Expression of Markers/Properties
Associated with Mesenchymal Stem Cells and Contributes to
Regulating Interactions with GB Cells. We next further investigated
the role of CMA in the switch in PC function induced by GB, by
Fig. 2. GB-induced CMA activity in PC is required for
the acquisition of an immunosuppressive function in
PC following interaction with GB. (A) Immunoblot of
LAMP-2A in PC of LAMP-2A KO (KO PC) or WT mice
(WT PC). (B) IL-2 production was measured by ELISA
after 72 h of stimulation of naïve OT-II CD4+ T cells in
response to OVA323–339 peptide presented by KO PC
conditioned (GB) or not (vehicle) by GB and compared
to controlWT PC. Values are normalized to basal levels
of IL-2 in resting T cells. Results are mean + SD from
5 to 6 different experiments; ***P < 0.001. (C) T cell
proliferation was measured by BrdU incorporation in
response to antigen presentation by WT PC and KO PC
previously conditioned (GB) or not (vehicle) by GB.
Results are mean + SD from 4 different experiments,
**P < 0.01. (D) Flow cytometry analysis of the ex-
pression of the costimulatory molecule CD80. Insert
numbers inside histograms represent MFI values. Bar
graphs show MFI values and percentages of cells
expressing CD80. Nonspecific fluorescence was mea-
sured using specific isotype monoclonal antibody and
GB cells were used as negative control. Data repre-
sents mean± SD obtained from at least 3 independent
experiments, **P < 0.01; ***P < 0.001. (E) mRNA ex-
pression of Il10 and Tgfb assessed by qPCR in GB-
conditioned WT PC and KO PC relative to basal levels
in cells cultured in the absence of GB. Data (mean + SD
from 3 different experiments) are presented as fold-
induction of mRNA expression following coculture
with GB for 72 h. *P < 0.05, **P < 0.01. (F) ELISA
measuring TNF-α secreted by WT PC and KO PC
cocultured with (GB) or without (vehicle) GB cells for
72 h. GB cells were used as negative control. All data
represent mean ± SD obtained from at least 3 inde-
pendent experiments; **P < 0.01.





















































analyzing changes in phenotype that may result from exposing
CMA-competent and CMA-defective PC to GB. We found in PC
that several markers associated with mesenchymal stem cells
(MSC) (14, 18, 20) were affected by the absence of CMA. As
expected, WT PC proliferation was inhibited by GB; however, KO
PC maintained their proliferative capacity in the presence of GB
(Fig. 6A). Levels of the angiogenic cytokine IL-6 produced by PC,
which is associated to altered PC proliferation and regenerative
properties (4, 18–20), were clearly up-regulated by the presence of
GB in WT PC. However, IL-6 expression remained unaffected
when KO PC were analyzed in the same conditions (Fig. 6B).
Levels of other angiogenic factors, such as vascular endothelial
growth factor (VEGF) and angiotensin I (18, 20) were also in-
creased in WT PC when cocultured with GB, whereas KO PC
production of those factors was not affected by GB. On the other
hand, the production of the antiangiogenic factor antithrombin
(36, 37) was highly induced in KO PC but not in WT PC, when
conditioned by the presence of GB (SI Appendix, Fig. S4 A–C). In
addition, the osteogenic factor, osteonectin (Sparc), which has
been reported to be associated to angiogenic inhibition and tumor
growth (38, 39), was also up-regulated in KO PC in presence of GB
(SI Appendix, Fig. S4D). Interestingly, when instead of the media
we directly analyzed the secreted vesicular fraction, we also iden-
tified increased levels of osteonectin and IL-6 in the vesicles se-
creted by KO PC in presence of GB (SI Appendix, Fig. S4 E and
H). Although low amounts of VEGF and antithrombin were also
detected in vesicles from bothWT PC and KO, the levels of VEGF
were only increased by GB in WT PC (SI Appendix, Fig. S4 E–G).
Other changes induced by GB in WT PC, including a reduction
in mitochondrial mass (SI Appendix, Fig. S5A) and changes in the
expression of associated mesenchymal markers Sca-1, CD105, and
CD90, did not occur in KO PC cocultured with GB (Fig. 6 C–E).
Fig. 3. GB-induced CMA in PC is required to stabilize
PC–GB interactions. (A) Proliferation of GB cells inter-
acting with WT PC (WT PCCGB) or KO PC (KO PCCGB),
represented as cumulative population doubling (CPD),
during different times of coculture was measured and
compared to proliferation of control GB cells. Results
are mean + SD of at least 3 different experiments; *P <
0.05. (B) Cell interactions between GB and WT PC or
KO PC cocultured during 72 h, detected by confocal
fluorescence microscopy. PC were previously stained
with CFSE (green) and GB cells express the RFP-protein
(red). Representative images are the merge of RFP and
CFSE fluorescence with the phase contrast image.
(Scale bars: 25, 50, and 75 μm.) (C) Detection of GB cell
death by LIVE/DEAD blue-fluorescent reactive dye
(blue-fluorescent dye), following coculture with WT PC
or KO PC for 48 and 72 h. MFI is shown in represen-
tative histograms and graph bar represents quantifi-
cation of dead cell percentages from at least
4 independent experiments, *P < 0.05 or ***P < 0.001.
(D) Detection of dead cells by blue-fluorescent reactive
dye of WT PC or KO PC in presence or not of GB cells
(GBCWT PC; GBCKO PC) after 72 h of coculture. (E) In-
teraction of WT PC and KO PC with GB cells. Images
obtained by scanning electron microscopy are repre-
sentative of at least 3 independent experiments. Arrows
indicate interaction through nanotubes (Upper) and
cytosol fusion (Lower) after 72 h of coculture. (Scale
bar, 10 μm.) (F) Magnified detail of disorganized pro-
trusions in contact areas of KO PC. (Scale bar, 5 μm.) (G)
Adhesion assay of GB cells expressing RFP with WT PC
or KO PC cocultured for 24 h. Graph represents per-
centage of adhesion relative to fluorescent levels
obtained in control cultures with GB cells alone of at
least 3 independent experiments; ***P < 0.001.









































































We also found that the expression of the interaction protein
occludin, which was reduced in WT PC conditioned by GB cells,
appear to be deregulated in KO PC, which showed high levels of
expression (Fig. 6F and SI Appendix, Fig. S5B). All of these data
together support that the induction of CMA caused by GB in PC,
in addition to down-regulating the immune function of PC, is also
essential to maintain the effective interaction of PC with GB cells
and to regulate markers/properties associated with MSC in PC
that may contribute to sustain tumor growth (Fig. 6G).
GB-Induced CMA in PC Assists Tumor Growth. We have seen pre-
viously that, when interacting with GB, PC fail to induce T cell
responses in vitro, and facilitate GB proliferation and tumor growth
in vivo (4). To determine if the induction of CMA caused by GB in
PCmight contribute in vivo to the regulation of those functions that
assist tumor growth, we first analyzed if CD4+ T cell responses
would also be affected by the lack of CMA in PC in our GB mouse
model (4). Purified CD4+ T cells from lymph nodes of mice
xenografted with WT PC and RFP+ GB cells revealed significant
decreased activation compared to cells isolated from control mice.
However, T cells isolated from mice xenografted with KO PC and
GB cells showed levels of proliferation and IL-2 expression similar
to those measured in T cells from control mice (Fig. 7 A and B).
Furthermore, flow cytometry analysis of those cells revealed that,
compared to T cells from control mice, T cells from mice grafted
with WT PC and GB presented significant higher levels of 2 coin-
hibitor receptors associated with suppression of T cell function in
the tumor microenvironment: PD-1 and cytotoxic T lymphocyte-
associated protein-4 (CTLA-4). However, T cells isolated from
mice grafted with KO PC and GB showed no significant increase in
the expression of those receptors (Fig. 7C and SI Appendix, Fig.
S6A). Corroborating those data, we also found high PD-1
expression in T cells infiltrating the meninges of mice that were
grafted with WT PC and GB, whereas mice that received KO PC
and GB did not show any infiltration in the meninges (Fig. 7D). In
the perivascular areas, where PC make contacts with GB cells,
approximately the same levels of T cell infiltration (40 to 60%)
were detected in mice with WT PC and GB and in mice that re-
ceived KO PC and GB. However, almost all T cells expressed
PD-1 in mice that received WT PC, but just 1 to 2% of T cells
expressed PD-1 in mice with KO PC (SI Appendix, Fig. S6B).
Supporting previous data, we also found increased expression of
the T regulatory cells transcription factor FoxP3 in isolated T cells
from cervical and maxillary lymph nodes and in T cells infiltrating
the perivascular areas close to meningeal and tumor areas (∼25%
of the total) of mice that were grafted with WT PC and GB (SI
Appendix, Fig. S7 A–C). Mice that were xenografted with KO PC
and GB showed increased levels of antigen-specific central mem-
ory (CD44+ CD62+) CD4+ and CD8+ T cells compared to those
xenografted with WT PC and GB (SI Appendix, Fig. S7 D–G).
Many T cells in the infiltrates showed an effector/memory CD44+
phenotype, and were surrounding perivascular areas near the tu-
mor area (ratio CD4+:CD8+ = 4:1). Mice that were xenografted
with KO PC and GB, presented higher levels of CD44+ cells and
increased infiltration of CD8+CD44+ T cells (ratio CD4+:CD8+ =
2:1) in those areas of the brain parenchyma where there were
barely any remaining GB cells (SI Appendix, Fig. S7 A and H).
Fig. 4. GB-induced CMA in PC prevents tumor cell
death. (A) ELISA measuring human GM-CSF levels
produced by GB cells at basal levels and conditioned
by WT PC (WT PCCGB) or KO PC (KO PCCGB) during 72 h.
*P < 0.05, ***P < 0.001. (B) ELISA measuring human
GM-CSF levels produced by GB cells at basal levels and
in presence of media obtained from cell cultures of
WT PC and GB or KO PCC and GB cocultured for 72 h.
All data represent mean ± SD from at least 3 in-
dependent experiments, *P < 0.05. (C) Flow cytometry
analysis of ROS production in GB cells conditioned by
WT PC (WT PCCGB) or KO PC (KO PCCGB) for 24 and 72 h.
ROS production in PC was not detectable. Dot plots
are representative experiments showing ROS pro-
duction at 72 h. Graph bar represents MFI values
normalized to values obtained from GB cultured alone
of at least 3 independent experiments, ***P < 0.001.
(D) Flow cytometry analysis of ROS production in GB
cells cultured with WT PC in the presence or absence
of conditioned media from 72-h cocultures of GB and
WT PC or GB and KO PC (ROS was not detectable in
PC). Data represent mean ± SD (MFI normalized to
values from control GB). of at least 3 independent
experiments; *P < 0.05. (E) Adhesion assay of GB cells
expressing RFP to a WT PC monolayer in presence of
conditioned media from cultures of GB and WT PC or
GB and KO PC. Equal values of adhesion were mea-
sured after 24 and 72 h. Graph represents percentage
of adhesion relative to fluorescent levels of control GB
cells alone of at least 4 independent experiments;
**P < 0.01, ***P < 0.001.





















































Interestingly, those areas also showed high expression of CD44,
possibly indicating glial activation (40) (SI Appendix, Fig. S7H).
We had seen previously that xenografted mice with WT PC and
GB show higher tumor growth than mice grafted with only GB (4).
Interestingly, we found only residual numbers of RFP+ GB cells in
the infiltrated areas of mice grafted with KO PC and GB (Fig. 7 E,
Left). Those cells were also negative for the proliferation marker
Ki67 (Fig. 7 E, Right). To confirm our in vitro data, we analyzed the
expression of LAMP-2A in GB tumor areas and compared it to
peritumoral areas in contact with blood vessels, where PC are
located and GB infiltrates. Xenografted mice with GFP+ WT PC
and GB cells showed stronger expression of LAMP-2A next to
perivascular areas than inside or outside the tumor area (Fig. 7F).
Those tumor infiltration areas expressing higher LAMP-2A levels
accumulated GFP+ PC. Confirming previous results, part of the
strong LAMP-2A expression colocalized with GFP+ PC, suggest-
ing that GB-interacting GFP+ PC may have higher CMA activity
than other areas inside or outside the tumor where endogenous PC
may be located (Fig. 7F and SI Appendix, Fig. S6C). Finally, sup-
porting that CMA activity was also induced in human tumors, we
found increased LAMP-2A expression around blood vessels of
brain human biopsies fromGB patients, where PC are situated and
GB infiltrates (Fig. 7G). PC were identified by the NG2 PC marker
colocalizing with LAMP-2A expression (SI Appendix, Fig. S6D).
Discussion
Several mechanisms have been reported to facilitate GB progres-
sion (6–10), including the formation of a functional network that
may require cell interactions for cell intercommunication and de-
livery of molecules that assist tumor survival (3, 4, 11). Tumor cell
infiltration and invasion in the brain parenchyma occurs through
white matter tracts, subpial spread, perineural region, and also
through perivascular areas where PC are situated, leading to direct
cell interactions between GB cells and PC (4, 5, 11–14). These
interactions, instead of promoting the PC inflammatory function
(16–19), make them acquire an immunosuppressive function that
assists in the establishment of immune tolerance and, therefore,
facilitates tumor growth (4). However, the mechanisms that regu-
late GB tumor cell–PC interactions and the induction of an im-
munosuppressive phenotype in those PC are currently unknown.
In this work, we report that GB induces CMA activity in PC,
and that this aberrant increase in CMA activity is the mechanism
responsible for 1) switching PC immune function and 2) pro-
moting more stable interactions with GB, which help maintaining
tumor survival and prevent secretion of proteins with antitumor
activity (Fig. 6G).
Our data show that the interaction of GB with PC induces up-
regulation of LAMP-2A protein levels, the lysosomal membrane
receptor for CMA, which leads to increased CMA activity. This
occurs preferentially in peritumoral areas, where GB cells are
actively interacting with the perivascular space where PC are lo-
cated (Fig. 7 F and G and SI Appendix, Fig. S6C). GB-mediated
up-regulation of LAMP-2A protein levels in PC occurs as a con-
sequence of a burst in ROS generation that follows GB–PC in-
teraction (Fig. 1). Our results indicate that production of high
levels of ROS starts shortly after interaction between PC and GB
occurs. Changes in ROS levels are hardly detected in nonhypoxic
PC (SI Appendix, Fig. S1A) but are rapidly produced by GB upon
interaction with PC (Fig. 1G). Confirming that the ROS burst is
necessary to up-regulate LAMP-2A protein levels in PC, we found
that this up-regulation was prevented in the presence of a ROS
scavenger (Fig. 1H). Furthermore, using a luciferase reporter
containing the promoter of the Lamp2 gene bearing ROS re-
sponsive elements (25, 26), we confirmed that Lamp2a was in-
duced in PC in response to ROS in PC grown in conditioned
media from GB–PC cocultures (SI Appendix, Fig. S1A). Induction
of Lamp2a expression mediated by increased generation of ROS
has been previously described in fibroblasts exposed to oxidative
stress (26). Our results support that GB may hijack this mecha-
nism, which cells use to activate CMA and cope with oxidative
stress, to instead induce changes in PC that eventually facilitate
tumor survival and progression.
Fig. 5. GB-induced CMA in PC prevents an anti-tumor
protein secretion to maintain GB cell survival. (A) Flow
cytometry analysis, using LIVE/DEAD blue-fluorescent
dye, GB cell death when cultured with WT PC in
presence or not of conditioned media from 72-h co-
cultures of GB and WT PC or GB and KO PC (PC death
cell was not detectable). MFI is shown in representa-
tive histograms and graph bar represents quantification
of dead cell percentages from at least 3 independent
experiments; *P < 0.05. (B) Flow cytometry analysis
of the percentage of GB cell death. GB cells were
cultured in presence of media obtained from cocul-
tures of GB and WT PC or GB and-KO cultured for
72 h and compared to cells grown in control GB cell
media. Data are mean ± SD of 3 independent ex-
periments; ***P < 0.001. (C) Detection of GB cell death
by blue-fluorescent dye, following cocultured with WT
PC in presence of conditioned media from 72-h cocul-
tures of GB and KO PC pretreated with trypsin or
RNase. Histograms are representative experiments of
the quantification shown in the bar graph. Data are
mean ± SD of 3 independent experiments. Values are
also shown for pretreated control media and media
from control GB cells, WT PC, or KO PC; **P < 0.01.









































































Our data corroborate previous studies from our group that
showed the ability of GB to prevent antitumor inflammatory re-
sponses in PC (4) and identify GB-induced CMA as a contributing
mechanism to that effect (Fig. 2). Indeed, when GB interacts with
CMA-deficient PC, these cells fail to acquire the antiinflammatory
phenotype and the immunosuppressive function usually seen
in GBCWT PC. Instead, PC become proinflammatory and able to
induce effective T cell responses (Fig. 2). Abnormal up-regulation
of CMA in PC could be an efficient way to degrade or interfere
with the generation and release of the cytotoxic products that
should contribute to the immune response of PC against the tu-
mor. By doing so, the activation of CMA in GBCPC would permit
instead the establishment of a GB-induced immunosuppressive
function in PC.
GB-induced CMA in PC is also required to maintain effective
interactions between GB cells and PC, which is crucial for tumor
cell survival and proliferation (Fig. 3). GB is able to recruit and
modify the function of different cell types in the brain, including
PC, to generate a microenvironment that favors tumor growth
and prevents an antitumor immune response. This is achieved
not only through the secretion of soluble mediators but also
through cell-to-cell direct communication mediated by nano-
tubes and extracellular secretory vesicles that can transport
proteins, metabolites, macromolecules, or even whole organelles
between cells (3, 41). We have found that, whereas GB estab-
lished an organized network of nanotube-mediated connections
with WT PC, it failed to do so in the presence of CMA-deficient
KO PC. Furthermore, the accumulation of vesicles that was
observed in the contact site between PC and GB were almost
absent in the presence of LAMP-2A–deficient PC. These data
suggest that CMA activity induced by GB in PC might contribute
to the turnover of proteins involved in the regulation of the
formation and maintenance of those nanotubes, and down-
regulate the generation and secretion of extracellular vesicles
that normally carry cytotoxic products able to kill tumor cells.
We propose that this cytotoxicity resulted directly from the
Fig. 6. GB-induced CMA in PC alters the expression of markers/properties associated with MSC and contributes to regulate interactions with GB cells. (A) Pro-
liferation ofWT PC and KO PC interacting with GB cells measured as CPD at different times of coculture compared to proliferation of control PC. Results aremean + SD
of at least 3 different experiments; **P < 0.01, ***P < 0.001. (B) Mouse IL-6 production was measured by ELISA in WT and KO PC cultured for 72 h with GB cells. All
data represent mean ± SD obtained from at least 3 independent experiments; **P < 0.01. (C–F) Flow cytometry analysis of the expression of Sca-1, CD105, and CD90 in
WT PC (Upper histograms) and KO PC (Lower histograms) conditioned or not by GB cells for 72 h. Gate strategy to separate both cell populations was performed as
indicated in Fig. 1E. Insert numbers inside histograms represent MFI values for representative plots. Bar graphs represent percentages of positive cells expressing every
marker. Nonspecific fluorescence was measured using isotypemonoclonal antibodies and GB cells were used as negative controls. Data represent mean ± SD obtained
from at least 3 independent experiments; *P < 0.05; **P < 0.01. (F) Flow cytometry analysis of the expression of occludin in WT PC (Upper histograms) and KO PC
(Lower histograms) conditioned or not by GB cells for 48 h. Insert numbers inside histograms represent MFI values for representative results. Bar graph represent
percentages of positive cells. Nonspecific fluorescence was measured using isotype monoclonal antibodies and GB cells were used as negative control. Data represent
mean ± SD obtained from at least 3 independent experiments; *P < 0.05. (G) Proposed model depicting how GB induced CMA affects the PC functions. GB-
induced CMA promotes an immunosuppressive function in PC that fails to support T cell responses GB (blue arrows). GB interaction with PC promotes a ROS
burst that leads to increased up-regulation of the LAMP-2A expression in PC (big blue arrow). LAMP2-A is delivered to the lysosomal membrane to increase
CMA activity (blue dashed arrows) (21, 31). The Hsc70 chaperone recognizes KFERQ motifs in CMA substrate proteins and with the help of its cochaperones,
delivers them to the lysosomal membrane where they interact with LAMP-2A and are translocated, not the lysosomal lumen assisted by a resident luminal
Hsc70. Modulation of the PC proteome eventually results in changes in programs of gene expression that include up-regulation of the antiinflammatory
cytokines TGF-β and IL-10, which exert a negative regulation on T cells and antigen presenting cells (blue arrows). T cell activation and proliferation are
affected and regulatory T cells are generated. The absence of costimulatory molecules, such as CD80 and CD86, and the expression of the negative
regulator PDL-1, also facilitate an immunosuppressive function in PC. Degradation of specific substrate proteins may also regulate distinct functions in PC
that are lost or gained as a consequence of the induction of CMA by GB. GB-induced CMA in PC also modulates their MSC-like properties and stabilizes GB–
PC interaction to facilitate tumor growth (big red arrow). Specifically, inhibition of the secretion of proteins that may have antitumor activity and an
increase in the secretion of vesicles with proregenerative factors, may also assist tumor proliferation (red dashed arrows).





















































Fig. 7. GB-induced CMA in PC assists tumor growth. (A) Activation-induced cell proliferation and (B) IL-2 production were measured in CD4+ T cells isolated from
maxillary and cervical lymph nodes from xenografted mice with WT PC and GB cells (WT PC+GB) or KO PC and GB cells (KO PC+GB) and compared to T cells from
control mice xenografted with GB cells or PBS (vehicle). Cells were activated ex vivo with anti-CD3 and anti-CD28 for 72 h. All data represents mean± SD of at least
3 independent experiments; *P < 0.05. (C) Flow cytometry analysis of the expression if coinhibitory receptors in CD4+ T cells isolated from lymph nodes (maxillary,
cervical, and axillary) from xenografted mice withWT PC and GB cells (WT PC+GB) or KO PC and GB cells (KO PC+GB) and compared to T cells isolated from control
mice xenografted with GB cells. *P < 0.05; **P < 0.01. (D) Expression of PD-1 was detected by immunofluorescence in T cells from the cerebrospinal fluid of
meninges of grafted mice with GB and WT PC. (Scale bar, 10 μm.) (E) GB tumor growth in mice that were xenografted with cocultures of WT PC+GB cells (GB/WT
PC) and compared to mice xenografted with KO PC+GB cells (GB/KO PC) (Scale bars of Left, 250 μm.) Right shows representative detail of proliferating GB cells,
which appear as intense RFP+ fluorescent spherical dividing cells (red) and Ki67
+ (green). Confocal microphotographs (1-μm-thick section). (Scale bar, 50 μm.) (F)
Expression of LAMP-2A in PC and GB cells in xenografts of cocultured PC expressing GFP (PC-GFP) and GB cells. Upper shows delimited tumor with heterogenous
and stronger expression of LAMP-2A in the right pole next to perivascular areas (arrows). Merged image of confocal microphotographs (1-μm-thick section) shows
the colocalization of LAMP-2A expression in the GB cells and perivascular cells. (Scale bar, 100 μm.) Lower shows PC in those tumor infiltration areas as GFP+ cells
(green). These cells accumulated in the ventral pole of the tumor (arrows). (Scale bar, 250 μm.) Nuclear staining by DAPI (blue) shows that tumor cellularity was
higher in the ventral pole (arrows). Strong LAMP-2A (red) expression in the ventral pole of the tumor is indicated (arrows) and compared to the rest of the tumor
where hardly any GFP+ PC are localized. Merged image shows the colocalization of grafted PC and the strong expression of LAMP-2A in the peritumoral areas and
around blood vessels, where also endogenous PC of the mice are situated. Insets show the areas in detail of bottom pictures. High power pictures showing GFP+
and LAMP-2A+ punctate pattern (arrowheads) colocalization around blood vessels (V). (Scale bar, 45 μm.) All Images are representative of data from GB+WT PC
grafted mice (12 tumors/15 grafted mice) and GB+KO PC grafted mice (0 tumors/15 grafted mice). Mice were analyzed 4 to 11 wk after graft. Images are
representative of at least 3 different experiments using U87 or U373 GB lines independently. (G) Representative images of LAMP-2A expression (arrows) in
perivascular areas (V) of 8 brain biopsies from GB patients compared to 6 control fields in the not infiltrated brain areas. (Scale bar, 50 μm.)









































































secreted components rather than from the inability to sustain
the tumor–PC interactions, because conditioned media from
GB–KO PC cocultures were able to kill GB cells even if they
were interacting with WT PC (Figs. 4 and 5).
Constitutive high levels of GM-CSF produced by GB have been
reported to promote immunosuppression of the antitumor im-
mune response (8, 42). Corroborating previously reported data, we
found production of higher levels of GM-CSF in GB following
interaction with WT PC compared to basal levels. Interestingly,
CMA-deficient PC also promoted significant changes in GB that
translated in production of even higher GM-CSF and ROS levels
(Fig. 4), which could be reproduced by culturing GB in condi-
tioned media from cultures of GB with KO PC (Fig. 4 B and E).
This increased production of GM-CSF and ROS correlated with
GB cell death (Fig. 5). These data suggest that the dual role of
GM-CSF as stimulatory or suppressive of the immune response
depends in part on the dose (8, 42), and on the establishment of
GB interactions with cells of the brain parenchyma.
Our data show that GB-induced CMA activity in PC regulates
markers/properties associated with MSC in those PC, including
proliferation, expression of MSC markers, production of cytokines,
and proregenerative factors (Fig. 6 and SI Appendix, Fig. S4), as
well as their immune function. Up-regulation of the expression of
occludin in PC, which is dependent on GB-induced CMA (Fig. 6F
and SI Appendix, Fig. S5B), might also contribute to the stabili-
zation of GB–PC interactions (34). This may account for the un-
stable interactions observed between GB and CMA-deficient PC.
We found that all changes detected on PC were dependent on GB-
induced CMA, which suggests that GBmay promote the abnormal
up-regulation of this selective form of autophagy in PC to subvert
PC’s antitumor responses through the degradation of proteins that
may participate in the expression of inflammatory mediators, the
regulation of MSC-like properties, or the maintenance of effective
cell-to-cell communication. An in-depth study of changes in the
proteome of WT or LAMP-2A–deficient PC in the presence of
GB will be required to identify CMA substrates that may be in-
volved in modulating all these changes.
In vitro and in vivo data also supports that GB-induced CMA in
PC is essential for PC to acquire an immunosuppressive function
(Fig. 6G), which prevents effective antitumor T cell responses.
Consequently, only when GB and WT PC were grafted, T cells
from tumor-bearing mice expressed higher levels of inhibitory re-
ceptors (Figs. 2 and 7 A–D), and showed decreased responses
to activation, which eventually resulted in increased tumor cell
survival and proliferation (Figs. 3, 6G, and 7E), and facilitated
tumor progression (Fig. 7E) (4). Those changes were not present
when GB was grafted with KO PC, which may account, at least in
part, for the hindered tumor progression observed in those
animals.
Multiple immune cell populations—including myeloid‐derived
suppressor cells, microglia, and astrocytes—might participate in
the suppression of the immune response in the tumor microen-
vironment. This may occur through the regulation of several
mechanisms that may be responsible for GB immune evasion (43,
44). Our work highlights PC as a cell type that is essential for the
establishment of immune evasion in GB. Modulation of CMA
activity, however, can revert the immunosuppressive phenotype
that PC acquire in the presence of GB and contribute to the
generation of an effective antitumor immune response.
In recent years, several preclinical and clinical studies have
demonstrated that interventions using immune checkpoint inhibi-
tion as a single therapy, including blockade of PD-1/PD-L1 or
CTLA-4/B7-1/B7-2 interactions, can be effective for several types
of cancer, including melanoma or lung cancer, but fail to induce
effective antitumor responses in others, such as GB (45, 46). The
lack of the generation of highly immunogenic antigens during GB
progression and the subsequent failure in the T cell response
seems to facilitate GB escape from the immune system, together
with the establishment of an immunosuppressive microenviron-
ment using mechanisms that may be resistant to checkpoint inhi-
bition (45, 46). Our results support that the induction of CMA in
PC caused by GB participates in the regulation not only of the
expression of coinhibitory receptors, such as PD-1 and CTLA-4,
but also of other mechanisms responsible for GB-induced immu-
nosuppression. Excitingly, when CMA activation is prevented in
PC, increased numbers of memory T cells are detected, which
correlates with efficient GB growth control. Those T cells may
represent cells that have been activated by tumor antigens and
might be able to generate an efficient antitumor response (Fig. 7
and SI Appendix, Figs. S6 and S7).
Our work shows that GB-induced CMA in PC may provide a
critical element for the local control of PC–tumor cell interaction
and for the down-regulation of the antitumor immune response.
Therefore, preventing the GB-induced up-regulation of CMA in
the contacting PC may represent a targeting strategy for the de-
velopment of new therapies against GB.
Materials and Methods
Mice. Six- to 8-wk-oldWTC57BL/6, C57BL/6-Tg (ACTB-EGFP)1Osb/J (Charles River
Laboratory), Tg(TcraTcrb)425Cbn/j (OT-II) TCR transgenic (Jackson Laboratory)
miceweremaintained in pathogen-free conditions in the animal facilities of the
University of Murcia and Biomedical Research Institute of Murcia-Arrixaca. All
animal procedures were approved and performed according to the guidelines
set by the University of Murcia Institutional Animal Care and Use Committee.
Cell Culture. Primary brain PC from mice were isolated and cocultured with GB
cells, at a ratio 1:1 for 12 to 72 h, as described previously (4). PC with impaired
CMA, were isolated from brains of Lamp2a−/− mice (47). Alternatively, Lamp2a
expression was silenced by transducing PC with lentivirus expressing Lamp2-
specific shRNAs as described in SI Appendix. Human GB cell lines U373-MG and
U87 were purchased from European Collection for Authenticated Cell Cul-
tures. Cell culture media obtained from 72-h cocultures of GB and PC was
concentrated using Amicon Ultra centrifugal filters 10k (Millipore) and used
10 times diluted. PC were pretreated with a ROS scavenger, NAc (Sigma) at
20 mM and after cocultured with GB for 48 h at 500 μM. DiD labeling solution
(Invitrogen), GFP-expressing PC, and GB expressing RFP were used for cell
tracking, cell population separation, and sorting (Sony SH800) as described
previously (4). For the vesicular fraction isolation, quantification, and function
in PC, please see SI Appendix.
Primary CD4+ T cells were isolated from lymph nodes using anti-CD4–
coupled magnetic beads (Life Technologies). Isolated T cells were stimu-
lated ex vivo with 0.5 μg/mL plate bound anti-CD3 and 0.5 μg/mL anti-CD28
(BD Biosciences). Functional assays of PC with T cells were carried out as
described previously (4).
Real-Time PCR (qPCR). cDNA was synthesized from total mRNA, and gene
expressionwas analyzed by real-time PCR using SYBRGreen in a StepOne Plus
Thermocycler (Applied Biosystems), as described previously (4). For primer
sequence information, please see SI Appendix.
Immunoblotting. Total cellular lysates were prepared using RIPA buffer (1%
Triton-X 100, 1% sodium deoxycholate, 0.1% SDS, 0.15 M NaCl, 0.01 M sodium
phosphate, pH 7.2). Primary antibodies used were rabbit anti-mouse LAMP-2A
(Invitrogen), rabbit anti-mouse GFP (Abcam), and anti–β-actin (Santa Cruz
Biotechnology). For plasmid transfection, reporter assays, and lentiviral in-
fection, please see SI Appendix.
ELISA. PC (5 × 104) were cultured with GB cells at 1:1 ratio in 96-well plates for
24 to 72 h. Mouse TNF-α, IL-6, VEGF (R&D Systems), angiotensin (Abcam),
antithrombin, and osteonectin (Abyntek) secreted by PC in the media or in
vesicles (for vesicles preparation, quantification and function, please see SI
Appendix) and GM-CSF (Diaclone) secretion by GB, as well as IL-2 (BD Biosci-
ences) production by T cells were measured by sandwich ELISA with specific
antimouse antibodies following the manufacturer’s recommendations.
Flow Cytometry Analysis. Lysotracker and mitotracker were used for lysosomes
and mitochondria tracking (Invitrogen). ROS production was measured using
the H2DCFDA probe (Invitrogen). Expression of CD80, CD90 (eBioscience), Sca-1
(Biolegend), CD105 (Abcam), occludin (ProSci Inc; Thermofisher), PD-1 (Novus),
CTLA-4, LAG-3, CD4, CD3, FoxP3 (eBioscience), CD44 (BD Biosciences), and
CD62L (Palex) were analyzed using DiD labeling solution for tracking and
separation of cells and specific anti-mouse antibodies. Labeled isotype
monoclonal antibodies were used on GB to determine background nonspecific
fluorescence. PC and GB cell death was determined using LIVE/DEAD Fixable





















































Blue Dead Cell Stain Kit, (ThermoFisher). Stained cells were analyzed by flow
cytometry using a FACSCanto flow cytometer (BD Bioscience) and data were
analyzed with Kaluza analysis software (Beckman Coulter).
Adhesion Assay. GB cells expressing RFP and previously irradiated to inhibit their
proliferation and just analyze cell adhesion, were cocultured on a monolayer
culture of WT PC or KO PC for 24 h. Cells were lysed after washing away non-
adhered cellswithmediaand remainingRFP fluorescence in thewells (belonging to
theGBthatadhered toPC)wasmeasuredat488nm(588-nmemission). Purified cell
media from cocultures of GB and Lamp2a−/− PC was treated with RNase (Qiagen)
or trypsin (Sigma) and added to PC, before or after 48 h of cocultured with GB.
Proliferation Assay. PC (5 × 104) were cultured with GB cells at 1:1 ratio in 6-
well plates for 24 to 72 h. Isolation, counting and cumulative population
doubling level weremeasured as previously described (4). In some cases, 5-(and
6)-Carboxyfluorescein diacetate succinimidyl ester (CFSE) was also used as cell
proliferation tracker (eBioscience). T cell proliferation was measured by BrdU
incorporation using a commercial kit (Roche), as previously described (4).
Xenografts. Cell pellets from human GB cells or GB cells coculturedwith murine
PC for 72 h (5 × 106 cells), were grafted into C57BL/6 mice brains. Xenografts
were performed as described previously in an immunocompetent mouse
model (4). Fifteen mice received xenografts and were analyzed in each ex-
perimental line (GB, GB+WT PC and GB+KO PC). Eleven weeks postgrafting,
mice were perfused using 4% paraformaldehyde (Panreac). Brains were em-
bedded in 30% sucrose (Sigma) and cut at 4-μm using a cryostat. For immu-
nohistochemistry in xenografts and GB patient samples, immunofluorescence,
and scanning electron microscopy, please see detailed SI Appendix, Supple-
mentary Materials and Methods.
Statistical Analysis. Differences between groups were analyzed by 1-way
ANOVA with a Tukey–Kramer posttest. Comparisons between data pairs
were analyzed using a t test. Statistical significance was defined as P < 0.05.
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